AI Article Synopsis
- COVID-19 significantly impacted daily practices in endocrinology, revealing important connections between endocrine and metabolic comorbidities and patient outcomes.
- Key endocrine factors in COVID-19 included diabetes, obesity, and low vitamin D levels, emphasizing the need for tailored prevention and management strategies.
- The European Society of Endocrinology (ESE) played a crucial role in supporting the endocrine community by adapting educational and advocacy efforts during the pandemic.
Article Abstract
Changes that COVID-19 induced in endocrine daily practice as well as the role of endocrine and metabolic comorbidities in COVID-19 outcomes were among the striking features of this last year. The aim of this statement is to illustrate the major characteristics of the response of European endocrinologists to the pandemic including the disclosure of the endocrine phenotype of COVID-19 with diabetes, obesity and hypovitaminosis D playing a key role in this clinical setting with its huge implication for the prevention and management of the disease. The role of the European Society of Endocrinology (ESE) as a reference point of the endocrine community during the pandemic will also be highlighted, including the refocusing of its educational and advocacy activities.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494341 | PMC |
| http://dx.doi.org/10.1530/EJE-21-0397 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!